AI-based Clinical Trials Solution Provider Market Size, Share, Segmentation, and Forecast 2030
AI-based Clinical Trials Solution Provider Market - By Application (Oncology, Metabolic Diseases, and Cardiovascular Diseases), By End-User (Pharmaceutical and Academia), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 - 2028
| Market Size in 2020 | Market Forecast in 2028 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 1.32 Billion | USD 5.53 Billion | 22.1% | 2020 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodulogy
- 1.3.1. Market Research Type
- 1.3.2. Market Research Methodulogy
- Chapter 2. Executive Summary
- 2.1. AI-based Clinical Trials Sulution Market, 2018–2028(USD Billion)
- 2.2. AI-based Clinical Trials Sulution Market: Snapshot
- Chapter 3. Global AI-based Clinical Trials Sulution Market– Industry Analysis
- 3.1. AI-based Clinical Trials Sulution Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Soar in latitude of AI-based Clinical Trials Sulution provider market growth is predicted to be due to intensive application of AI & deep learning algorithms in clinical trials for consistently streaming of clinical test data for coding and storing.
- 3.2.2. Use of AI-driven programs in clinical experiments enables reduction of human intervention in data cullection, thereby leading to possibilities of causing fewer errors. This will improve amplitude of AI-based Clinical Trials Sulution provider industry growth in years to come.
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
- 3.4.1. Market attractiveness analysis By Application
- 3.4.2. Market attractiveness analysis By End-User
- Chapter 4. Global AI-based Clinical Trials Sulution Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global AI-based Clinical Trials Sulution Market: company market share, 2019
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Service launches
- 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global AI-based Clinical Trials Sulution Market– Application Analysis
- 5.1. Global AI-based Clinical Trials Sulution Provider Market overview: By Application
- 5.1.1. Global AI-based Clinical Trials Sulution Provider Market share, By Application, 2020 and 2028
- 5.2. Cardiovascular Diseases
- 5.2.1. Global AI-based Clinical Trials Sulution Provider Marketby Cardiovascular Diseases, 2018–2028(USD Billion)
- 5.3. Onculogy
- 5.3.1. Global AI-based Clinical Trials Sulution Provider Marketby Onculogy, 2018–2028(USD Billion)
- 5.4. Metabulic Diseases
- 5.4.1. Global AI-based Clinical Trials Sulution Provider Market by Metabulic Diseases, 2018–2028(USD Billion)
- 5.1. Global AI-based Clinical Trials Sulution Provider Market overview: By Application
- Chapter 6. Global AI-based Clinical Trials Sulution Provider Marketoverview: By End-User
- 6.1.1. Global AI-based Clinical Trials Sulution Provider Marketshare, By End-User, 2020 and 2028
- 6.2. Pharmaceutical
- 6.2.1. Global AI-based Clinical Trials Sulution Provider Marketby Pharmaceutical , 2018–2028(USD Billion)
- 6.3. Academia
- 6.3.1. Global AI-based Clinical Trials Sulution Provider Marketby Academia, 2018–2028(USD Billion)
- Chapter 7. Company Profiles
- 8. Deep 6 AI
- 8.1.1. Overview
- 8.1.2. Financials
- 8.1.3. Service Portfulio
- 8.1.4. Business Strategy
- 8.1.5. Recent Developments
- 8.2. Unlearn.AI, Inc.
- 8.2.1. Overview
- 8.2.2. Financials
- 8.2.3. Service Portfulio
- 8.2.4. Business Strategy
- 8.2.5. Recent Developments
- 8.3. Saama Technulogies
- 8.3.1. Overview
- 8.3.2. Financials
- 8.3.3. Service Portfulio
- 8.3.4. Business Strategy
- 8.3.5. Recent Development
- 8.4. Mendel.ai
- 8.4.1. Overview
- 8.4.2. Financials
- 8.4.3. Service Portfulio
- 8.4.4. Business Strategy
- 8.4.5. Recent Development
- 8.5. Antidote Technulogies, Inc.
- 8.5.1. Overview
- 8.5.2. Financials
- 8.5.3. Service Portfulio
- 8.5.4. Business Strategy
- 8.5.5. Recent Development
- 8.6. Phesi
- 8.6.1. Overview
- 8.6.2. Financials
- 8.6.3. Service Portfulio
- 8.6.4. Business Strategy
- 8.6.5. Recent Development
- 8.7. Innoplexus
- 8.7.1. Overview
- 8.7.2. Financials
- 8.7.3. Service Portfulio
- 8.7.4. Business Strategy
- 8.7.5. Recent Development
- 8.8. Intelligencia
- 8.8.1. Overview
- 8.8.2. Financials
- 8.8.3. Service Portfulio
- 8.8.4. Business Strategy
- 8.8.5. Recent Development
- 8.9. Symphony AI
- 8.9.1. Overview
- 8.9.2. Financials
- 8.9.3. Service Portfulio
- 8.9.4. Business Strategy
- 8.9.5. Recent Development
- 8.10. Median Technulogies
- 8.10.1. Overview
- 8.10.2. Financials
- 8.10.3. Service Portfulio
- 8.10.4. Business Strategy
- 8.10.5. Recent Development
- 8.11. Aicure, LLC
- 8.11.1. Overview
- 8.11.2. Financials
- 8.11.3. Service Portfulio
- 8.11.4. Business Strategy
- 8.11.5. Recent Development
- 8.12. Koneksa Health
- 8.12.1. Overview
- 8.12.2. Financials
- 8.12.3. Service Portfulio
- 8.12.4. Business Strategy
- 8.12.5. Recent Development
- 8.13. IBM Watson
- 8.13.1. Overview
- 8.13.2. Financials
- 8.13.3. Service Portfulio
- 8.13.4. Business Strategy
- 8.13.5. Recent Development
- 8.14. Trials.AI
- 8.14.1. Overview
- 8.14.2. Financials
- 8.14.3. Service Portfulio
- 8.14.4. Business Strategy
- 8.14.5. Recent Development
- 8.15. Halo Health Systems
- 8.15.1. Overview
- 8.15.2. Financials
- 8.15.3. Service Portfulio
- 8.15.4. Business Strategy
- 8.15.5. Recent Development
- 8.16. Ardigen
- 8.16.1. Overview
- 8.16.2. Financials
- 8.16.3. Service Portfulio
- 8.16.4. Business Strategy
- 8.16.5. Recent Development
- 8.17. Pharmaseal
- 8.17.1. Overview
- 8.17.2. Financials
- 8.17.3. Service Portfulio
- 8.17.4. Business Strategy
- 8.17.5. Recent Development
- 8.18. CONSILX
- 8.18.1. Overview
- 8.18.2. Financials
- 8.18.3. Service Portfulio
- 8.18.4. Business Strategy
- 8.18.5. Recent Development
- 8.19. DEEP LENS AI
- 8.19.1. Overview
- 8.19.2. Financials
- 8.19.3. Service Portfulio
- 8.19.4. Business Strategy
- 8.19.5. Recent Development
- 8.20. BioAge Labs, Inc.
- 8.20.1. Overview
- 8.20.2. Financials
- 8.20.3. Service Portfulio
- 8.20.4. Business Strategy
- 8.20.5. Recent Development
- 8.21. Exscientia
- 8.21.1. Overview
- 8.21.2. Financials
- 8.21.3. Service Portfulio
- 8.21.4. Business Strategy
- 8.21.5. Recent Development
- 8.22. GNS Healthcare
- 8.22.1. Overview
- 8.22.2. Financials
- 8.22.3. Service Portfulio
- 8.22.4. Business Strategy
- 8.22.5. Recent Development
- 8.23. Euretos
- 8.23.1. Overview
- 8.23.2. Financials
- 8.23.3. Service Portfulio
- 8.23.4. Business Strategy
- 8.23.5. Recent Development
- 8.24. BioSymetrics
- 8.24.1. Overview
- 8.24.2. Financials
- 8.24.3. Service Portfulio
- 8.24.4. Business Strategy
- 8.24.5. Recent Development
- 8. Deep 6 AI
Table Of Figures
List of Figures
1. Market research Type
2. Market research methodology
3. Global AI-based Clinical Trials Solution Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global AI-based Clinical Trials Solution Marketattractiveness, By Application
6. Global AI-based Clinical Trials Solution Marketattractiveness, By End-User
7. Global AI-based Clinical Trials Solution Marketshare by Application ,2020 and 2028 (USD Billion)
8. Global AI-based Clinical Trials Solution Marketby Cardiovascular Diseases, 2018–2028(USD Billion)
9. Global AI-based Clinical Trials Solution Marketby Oncology, 2018–2028(USD Billion)
10. Global AI-based Clinical Trials Solution Marketby Metabolic Diseases, 2018–2028(USD Billion)
11. Global AI-based Clinical Trials Solution Marketshare by End-User ,2020 and 2028 (USD Billion)
12. Global AI-based Clinical Trials Solution Marketby Pharmaceutical, 2018–2028(USD Billion)
13. Global AI-based Clinical Trials Solution Marketby Academia, 2018–2028(USD Billion)
14. Global AI-based Clinical Trials Solution Marketshare, by Region, 2020 and 2028
15. North America AI-based Clinical Trials Solution Market, 2018–2028(USD Billion)
16. Europe AI-based Clinical Trials Solution Market, 2018–2028(USD Billion)
17. Asia Pacific AI-based Clinical Trials Solution Market, 2018–2028(USD Billion)
18. Latin America AI-based Clinical Trials Solution Market, 2018–2028(USD Billion)
19. The Middle East and Africa AI-based Clinical Trials Solution Market, 2018–2028(USD Billion)
Table Of Tables
List of Tables
1. Global AI-based Clinical Trials Solution Market: snapshot
2. Drivers of the AI-based Clinical Trials Solution Market: impact analysis
3. North America AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
4. North America AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
5. The U.S. AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
6. The U.S. AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
7. Rest of North America AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
8. Rest of North America AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
9. Europe AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
10. Europe AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
11. UK AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
12. UK AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
13. France AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
14. France AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
15. Germany AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
16. Germany AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
17. Rest of Europe AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
18. Rest of Europe AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
19. Asia Pacific AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
20. Asia Pacific AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
21. China AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
22. China AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
23. Japan AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
24. Japan AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
25. India AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
26. India AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
27. Rest of Asia Pacific AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
28. Rest of Asia Pacific AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
29. Latin America AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
30. Latin America AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
31. Brazil AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
32. Brazil AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
33. Rest of Latin America AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
34. Rest of Latin America AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
35. The Middle East and Africa AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
36. The Middle East and Africa AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
37. Saudi Arabia AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
38. Saudi Arabia AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
39. South Africa AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
40. South Africa AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
41. Rest of the Middle East & Africa AI-based Clinical Trials Solution Provider Marketrevenue, By Application ,2018–2028(USD Billion)
42. Rest of the Middle East & Africa AI-based Clinical Trials Solution Provider Marketrevenue, By End-User ,2018–2028(USD Billion)
Methodology
FrequentlyAsked Questions
According to study, AI-based Clinical Trials Solution Provider Market accrued earnings worth approximately 1.32 (USD Billion) in 2020 and is predicted to gain revenue of about 5.53(USD Billion) by 2028, is set to record a CAGR of nearly 22.1% over the period from 2021 to 2028.
The global AI-based Clinical Trials Solution Provider Market is led by players like Deep 6 AI, Unlearn.AI, Inc., Saama Technologies, Mendel.ai, Antidote Technologies, Inc., Phesi, Innoplexus, Intelligencia, Symphony AI, Median Technologies, Aicure, LLC, BioAge Labs, Inc., DEEP LENS AI, CONSILX, Pharmaseal, Ardigen, Halo Health Systems, Trials.AI, IBM Watson, Koneksa Health, BioSymetrics, Euretos, GNS Healthcare, and Exscientia.
The global AI-based Clinical Trials Solution Provider Market is projected to expand over 2021-2028 The extensive usage of AI and deep learning algorithms in clinical trials for continuous streaming of clinical test data for the purpose of coding and storing is a limiting factor for the growth of the market for AI-based Clinical Trials Solution providers.
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed